Scientists have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumor growth, in early stage research.
A new study associated obesity with a 34% higher risk of death in pre-menopausal women with early breast cancer susceptible to higher hormone estrogen levels.
New technology can improve imaging on glioblastoma multiforme tumors (a form of brain tumor), which may offer important treatment information and options.
Positron emission tomography (PET) scans before surgery did not significantly change the surgical treatment of colorectal cancer which has spread to the liver.
New study finds that breastfeeding, taking oral contraceptives and tubal ligation may reduce ovarian cancer risk for women with BRCA1 and BRCA2 genes mutations.
Rectal cancer patients may tolerate treatment if they receive chemotherapy before radiation therapy and surgery, as new research shows it may be more tolerable.
Breast cancer patients can benefit from a brief, 5-week psychological intervention after surgery, in dealing with the stress of the diagnosis and operation.
Patients with pancreatic cancer have a different and distinct profile of specific bacteria in their saliva, even compared to patients with other cancers.
Minimally invasive robot-assisted radical prostatectomy (RARP) is as safe as open surgery for patients over age 65, but it is more expensive.
Targeted therapy for patients with lung adenocarcinoma can help transform treatment for the disease, as many patients have specific genetic characteristics.
A diet rich in complex carbohydrates and fiber was associated with lower prostate cancer risk, according to an analysis of medical records showed.
About 70% of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast.
Researchers believe rapid resistance to vemurafenib (a treatment for a type of advanced melanoma) could be prevented by blocking a druggable family of proteins.
Two new studies show that lifestyle changes like healthy eating and regular exercise can decrease biomarkers related to breast cancer recurrence and mortality.
A review showed radiofreqeuncy ablation & complete endoscopic resection to be equally effective against dysplastic Barrett's esophagus which may lead to cancer.
Men who received radiation therapy for prostate cancer were more likely to develop bladder or rectal cancer, compared to those patients treated otherwise.
Overall survival for metastatic prostate cancer patients improved by more than a year when they received docetaxel at the start of androgen deprivation therapy.
A combination chemotherapy regimen administered after radiation therapy improved survival in adults with low-grade gliomas, a form of brain cancer, compared to taking radiation therapy on its own.
In the largest clinical trial for HER2-positive breast cancer, lapatinib did not add benefit to the standard trastuzumab therapy administered after surgery.
Research finds that adding goserelin to breast cancer chemotherapy treatment may reduce the risk of early menopause and infertility, and even improve survival.
A phase 3 study shows that adding the chemotherapy drug docetaxel to standard hormone therapy extends survival for men with prostate cancer by about 10 months.
A new type of personalized immunotherapy ("adoptive T cell therapy") showed striking results in a small phase 2 study for women with advanced cervical cancer.
Late-stage prostate cancer patients, who had not yet received chemotherapy, benefited from an experimental drug in a phase 3 trial in terms of overall survival.
Scientists relate the difference between the responses to an experimental immunotherapy melanoma treatment primarily to the size of the tumor before treatment.
A bilateral salpingo-oophorectomy (surgical removal of ovaries and fallopian tubes) reduced the risk of death for women with BRCA1-associated breast cancer.
A phase 1 study for an advanced bladder cancer drug showed promising results in patients with certain tumor types who did not respond to other treatments.
30% of cancer patients endure persistent fatigue for years after treatment, affecting their quality of life, leading to the creation of new clinical guidelines.
According to researchers, women who have survived a childhood cancer have 4x higher breast cancer risk, even if they were not exposed to chest radiation then.
In a study, ceritinib shrank tumors in patients with ALK+ non-small cell lung cancer, regardless of prior treatment, in general.
New guidelines for prostate cancer have been issued by the American Cancer Society, focusing on side-effects and follow-up care for patients after treatment.